Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study.
about
Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join ForcesImproving quality of care in inflammatory bowel disease: what changes can be made today?Gastroenterologists' Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale SurveyMicrobial imbalance and intestinal pathologies: connections and contributionsThe relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamineIBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study.Inflammatory bowel disease: a Canadian burden of illness reviewHealth determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing.Sense of coherence in patients with inflammatory bowel diseaseInflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications.Ulcerative colitis: current pharmacotherapy and future directions.Sick leave and disability pension in inflammatory bowel disease: a systematic review.Impact of inflammatory bowel disease on disability.The impact of moderate-to-severe Crohn's Disease on employees' salary growth.Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.The biologics of ulcerative colitis.Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease.Development and Validation of the Short Crohn's Disease Work Disability Questionnaire.Health care costs associated with Australian tertiary inflammatory bowel disease care.Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study.Low Risk of Unemployment, Sick Leave, and Work Disability Among Patients with Inflammatory Bowel Disease: A 7-year Follow-up Study of a Danish Inception Cohort.Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions.Measuring Disability in IBD: The IBD Disability Index.Fatigue management in patients with IBD: a randomised controlled trial.Anaemia in inflammatory bowel disease: a population-based 10-year follow-up.Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics.Preventing disability in inflammatory bowel disease.Quality of life in patients with inflammatory bowel disease: importance of clinical, demographic and psychosocial factors.Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease.Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study.Alterations in brain grey matter structures in patients with crohn's disease and their correlation with psychological distress.Cost-utility Analysis: Thiopurines Plus Endoscopy-guided Biological Step-up Therapy is the Optimal Management of Postoperative Crohn's Disease.Use of telemedicine in inflammatory bowel disease: a real monitoring option?TNF-α inhibits SCF, ghrelin, and substance P expressions through the NF-κB pathway activation in interstitial cells of Cajal.Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis.The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases.Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study
P2860
Q26765948-87CD74FE-97F3-4B6D-9325-E79943951CBDQ26859105-19CA9E2D-3A2B-4EAC-B7A3-03BF0996C406Q30489693-96294421-3087-4E86-9B77-D40D22BF52DEQ34241115-2BF3E645-98BC-4ECA-AB99-2A8D2BF1AE65Q35148270-A586FDC6-2E0C-49EB-A8DB-94630F176DC4Q35926068-8F6F9761-3A69-41D4-A4DF-B175D1CE5E10Q36391797-C5E3A365-8B80-4BD2-A69D-FF5C16962252Q37469231-C294030F-5EC7-4659-8337-B696885C6374Q37542550-AD4A1FCA-BD1C-4FAF-8035-981A619E21DAQ37597661-45F6177A-1D3B-4BBA-9E8E-7E4B613990A2Q38217653-385445C9-862B-48EE-BCEF-79F497378697Q38227060-EBFB8C32-87AA-4BD9-A5FE-3BDDE42E1431Q38251199-03795142-9D67-47B9-A282-77D472DCD373Q38419603-3AA7F8C7-ADBE-40B8-9A2F-5F3C78525450Q38752119-6403E982-E11F-4A20-9020-C42AEE6B5F90Q38775580-8A928F9A-B736-42B1-9EE1-8A57C1BB464DQ39037681-87083CF5-8DF1-46AD-B58F-DA0D624071BFQ39173519-5F86AFA2-94D0-4C7D-A089-1FB3792CF8E4Q39557707-7451A90E-8308-414B-934E-1060362AC4DEQ40199705-725AB4E7-5E02-48FD-AE41-88E1F3C5223EQ40473404-D18E5778-4E8E-4338-B5CB-BB8B80455DDEQ40747902-5764524F-EEBD-4C9C-A6A3-E4AD8788B570Q41608439-A4F03510-57FF-427F-B2E5-5F93B3487D10Q42243615-0E2884C7-E4D1-47BD-AD00-66C858A43347Q43440036-A4708744-69AC-4F3F-BA06-518DC53CA50EQ45236548-C3E6D5C3-0129-4656-AA4D-CC06D400AC9EQ45308690-A6465DD3-6916-4F23-A246-5B92E5E6BE18Q45338711-7ACCBB71-E632-4A94-9DBD-8A7B7103E294Q45718672-06D29948-B817-49B1-9407-C023BBFF8C4DQ47155609-445611EF-E3AD-497D-9C52-F958C51A70B9Q47552171-D0F7432C-B9F2-4C6C-B135-EBB82F0FE735Q47712418-55CCA670-B762-4E1C-BEFD-2A03C2C87C35Q48530814-93D41305-B05A-4B96-B3EE-2664E823A1FBQ51295017-B0D8911B-8035-4772-9769-26C50872BE08Q54979996-2A0231F1-C733-4B00-8EEB-4D4BA5DB8446Q55128199-D6278B27-F650-481D-A772-DDE24666E493Q55392751-07BE63AD-0A97-4D7F-8C1C-F01038F92FCAQ57193103-7162AC05-92FE-4C5B-83E1-1C35A99F5D0C
P2860
Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Work disability in inflammator ...... results from the IBSEN Study.
@en
Work disability in inflammator ...... results from the IBSEN Study.
@nl
type
label
Work disability in inflammator ...... results from the IBSEN Study.
@en
Work disability in inflammator ...... results from the IBSEN Study.
@nl
prefLabel
Work disability in inflammator ...... results from the IBSEN Study.
@en
Work disability in inflammator ...... results from the IBSEN Study.
@nl
P2093
P50
P1433
P1476
Work disability in inflammator ...... results from the IBSEN Study.
@en
P2093
IBSEN Group
Inger Camilla Solberg
Magne Henriksen
Milada Cvancarova
P304
P356
10.1136/GUTJNL-2012-302311
P407
P577
2012-06-20T00:00:00Z